Literature DB >> 26149299

Early goal-directed therapy in the treatment of sepsis: the times have changed but not the therapy and benefit to patients.

Anja Kathrin Jaehne1, Dhafer Salem, Juan Domecq Garces.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26149299     DOI： 10.1007/s00134-015-3927-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  A comparison of observational studies and randomized, controlled trials.

Authors:  K Benson; A J Hartz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Misleading funnel plot for detection of bias in meta-analysis.

Authors:  J L Tang; J L Liu
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

3.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

Review 4.  Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.

Authors:  Andrew Anglemyer; Hacsi T Horvath; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2014-04-29

Review 5.  A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators.

Authors:  D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young
Journal:  Intensive Care Med       Date:  2015-05-08       Impact factor: 17.440
  5 in total
  1 in total

1.  Early goal-directed therapy in the treatment of sepsis: response to comments by Jaehne et al.

Authors:  Derek Angus; Sandra Peake; Kathy Rowan
Journal:  Intensive Care Med       Date:  2015-07-07       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.